PNC Financial Services Group Inc. lifted its stake in shares of DaVita Inc. (NYSE:DVA – Free Report) by 0.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,854 shares of the company’s stock after purchasing an additional 118 shares during the period. PNC Financial Services Group Inc.’s holdings in DaVita were worth $1,922,000 as of its most recent filing with the SEC.
Several other large investors have also modified their holdings of DVA. SBI Securities Co. Ltd. bought a new position in DaVita in the fourth quarter worth about $41,000. Quarry LP bought a new position in DaVita in the third quarter worth about $60,000. Venturi Wealth Management LLC lifted its holdings in DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after acquiring an additional 152 shares during the last quarter. Versant Capital Management Inc lifted its holdings in DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after acquiring an additional 169 shares during the last quarter. Finally, Blue Trust Inc. lifted its holdings in DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after acquiring an additional 131 shares during the last quarter. Institutional investors own 90.12% of the company’s stock.
DaVita Price Performance
Shares of NYSE:DVA opened at $143.56 on Friday. The firm’s 50 day moving average is $158.92 and its two-hundred day moving average is $157.60. DaVita Inc. has a 52 week low of $125.64 and a 52 week high of $179.60. The firm has a market capitalization of $11.48 billion, a P/E ratio of 13.37, a PEG ratio of 1.07 and a beta of 0.99. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on the stock. Cowen reissued a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. Finally, Barclays raised their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $166.33.
View Our Latest Analysis on DVA
DaVita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Stories
- Five stocks we like better than DaVita
- Learn Technical Analysis Skills to Master the Stock Market
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Why Are These Companies Considered Blue Chips?
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Where Do I Find 52-Week Highs and Lows?
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.